Bibliographie Introduction








télécharger 344.58 Kb.
titreBibliographie Introduction
page9/10
date de publication06.01.2017
taille344.58 Kb.
typeBibliographie
b.21-bal.com > droit > Bibliographie
1   2   3   4   5   6   7   8   9   10

7. CONCLUSION


Nous avons pu entrevoir, à travers cette revue exhaustive de la littérature, de multiples mécanismes physiopathologiques d’élévation des troponines, en rapport avec des pathologies cardiaques et extracardiaques très variées.

La pertinence de ce marqueur est incontestable dans le domaine de la coronaropathie. Son utilisation permet la détermination d’une population ayant un surrisque de décès d’origine cardiaque et de mortalité globale à court et moyen terme. Par conséquent, grâce à cet outil, les cliniciens doivent s’attacher à optimiser la prise en charge des coronariens, aussi bien dans le temps que dans la manière d’utiliser les thérapeutiques recommandées par les sociétés savantes.

En outre, il faut retenir les résultats encourageants de nombreuses grandes études qui se sont intéressées à la troponine I ou T comme marqueur pronostique dans le cadre de pathologies extracoronariennes très diverses : sepsis, amylose cardiaque, cardiomyopathie aux anthracyclines, accident vasculaire cérébral, insuffisance cardiaque et insuffisance rénale chronique. L’élévation de cette enzyme, pourtant hautement sensible et spécifique au myocarde, souligne, dans ces diverses pathologies, une surmorbidité et une surmortalité, non seulement cardiovasculaire mais aussi globale.

Par ailleurs, le problème des faux positifs des troponines doit être envisagé uniquement dans des contextes très particuliers, minoritaires en pratique. Enfin, le domaine des faux négatifs fait l’objet de recherches expérimentales animales, dont les conclusions et extrapolations chez l’homme ne sont pas d’actualité.


  1. iBabuin L et al. Troponin : the biomarker of choice for the detection of cardiac injury. CMAJ. 2005; 173 : 1191-1202.

  1. iiCapolaghi B et al. Recommandations sur la prescription, le dosage et l’interprétation des troponines cardiaques. Ann Biol Clin 2005 ; 63 (3) : 245-261.

  1. iiiBertinchant JP et al. Place du dosage des troponines. EMC-cardiologie angéiologie 2004; 317-322.

  1. ivApple FS. Analytical issues for cardiac troponin. Prog Cardiovasc Dis. 2004; 47 : 189-195.

  1. vWu AH et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice : recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem. 1999; 45 : 1104-1121.

  1. viPanteghini M et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem. 2004; 50 : 327-332.

  1. viiAlpert JS et al. Myocardial infarction redefined a consensus document of the Joint European Society of Cardiology/ American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000; 36 (3) : 959-69.

  1. viiiChristenson RH et al. Evidence based approach to practice guides and decision threshold for cardiac markers. Scand J Clin Lab Invest. 1999; 230 : 90-102.

  1. ixWu AH et al. Biochemical markers of cardiac damage : from traditional enzymes to cardiac-specific proteins. Scand J Clin Lab Invest. 1999; 230 : 74-82.

  1. xWu AH et al. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparaison assays for troponin T and I. Clin Chem. 1998 ; 44 : 1198-1208.

  1. xiHamm CW et al. Risk stratifying acute coronary syndromes : gradient of risk and benefit. Am Heart J. 1999; 138 : S6-S11.

  1. xiiWu AH et al. Use of cardiac markers as assessed by outcomes analysis. Clin Biochem. 1997 ; 30: 339-350.

  1. xiiiLindahl B et al. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol. 1997; 29 : 43-51.

  1. xivHamm CW et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. C7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med. 1999; 340 : 1623-1632.

  1. xvAlpert JS et al. A call for universal definitions in cardiovascular diseases. Circulation 2006; 114 : 757-758.

  1. xviRoger VL et al. Redefinition of myocardial infarction : prospective evaluation in the community . Circulation 2006; 114 : 790-797.

  1. xviiOhtani T et al. Association between cardiac troponin T elevation and angioscopic morphology of culprit lesion in patients with non-ST-segment elevation acute coronary syndrome. Am Heart J. 2005; 150 : 227-233.

  1. xviiiDokainish H et al. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but non critical epicardial coronary disease : a TACTIS-TIMI-18 substudy. J Am Coll Cardiol. 2005; 45 : 19-24.

  1. xixMahajan N et al. Elevated troponin level is not synonymous with myocardial infarction. Int J Cardiol. 2006; 111 : 442-449.

  1. xxEtievent JP et al. Use of cardiac troponin I as a marker for myocardial ischemia in patients undergoing major noncardiac surgery. Ann Thorac Surg. 1995; 40 : 1192-1194.

  1. xxiAdams JE et al. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med. 1994; 330 : 670-674.

  1. xxiiJanuzzi JL et al. A comparison of cardiac troponin T and CPK-MB for patient evaluation after cardiac surgery. J Am Coll Cardiol. 2002; 39 : 1518-1523.

  1. xxiiiFellahi JL et al. Short- and long-term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology 2003; 99 : 270-274.

  1. xxivLehrke S et al. Cardiac troponin T for prediction of short- and long-term morbidity and mortality after elective open heart surgery. Clin Chem. 2004; 50 : 1560-1567.

  1. xxvThielmann M et al. Risk stratification with cardiac troponin I in patients undergoing elective coronary artery bypass surgery. Eur J Cardiothorac Surg. 2005; 27 : 861-869.

  1. xxviCosgrave J. et al. Troponin T elevation after coronary bypass surgery : clinical relevance and correlation with perioperative variables. J Cardiovasc Med. 2006 ; 7 (9) : 669-674.

  1. xxviiLandesberg G et al. The role of perioperative ischemia, preoperative thallium scanning and coronary revascularisation. J Am Coll Cardiol. 2004 ; 44 : 569-575.

  1. xxviiiKim LJ et al. Cardiac troponin I predicts short-term mortality in vascular surgery patients. Circulation 2002; 106 : 2366-2371.

  1. xxixDevereaux PJ et al. Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery : a review. CMAJ. 2005; 27 : 173-180.

  1. xxxFilipovic M. et al. Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery disease. J Am Coll Cardiol. 2003; 42 (10) : 1767-1776.

  1. xxxiLopez-Jimenez F et al. Prognostic value of cardiac troponin T after noncardiac surgery : 6-month follow-up data. J Am Coll Cardiol. 1997; 29 (6) : 1241-1245.

  1. xxxiiDetre K et al. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart Lung and Blood Institute Registry. N Engl J Med. 1988; 318 (5) : 265-270.

  1. xxxiiiBertinchant JP et al. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol. 1999; 84 : 51-58.

  1. xxxivNageh T et al. Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease. Heart 2005; 91 : 1181-1186.

  1. xxxvOkmen E et al. Correlations between cardiac troponin I, cardiac troponin T and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker. J Invasive Cardiol. 2005; 17 : 63-70.

  1. xxxviKorff S et al. Differential diagnosis of elevated troponins. Heart 2006 ; 92 : 987-993.

  1. xxxviiNienhuis MB et al. Prognostic importance of troponin T and creatinin kinase after elective angioplasty. Int J Cardiol. 2006; Déc 18 (article en cours de soumission)

  1. xxxviiiOhlmann P. et al. Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction. Am Heart J. 2006; 152 (6) : 1161-1167.

  1. xxxixPham MX et al. Prognostic value of low-level cardiac troponin I elevations in patients without definite acute coronary syndromes. Am Heart J. 2004; 148 : 776-782.

  1. xlBarasch E et al. Elevated cardiac troponin levels do not predict adverse outcomes in hospitalized patients without clinical manifestations of acute coronary syndromes. Cardiology 2000; 93: 1-6.

  1. xliSrivathsan K et al. Cardiovascular outcome in hospitalized patients with minimal troponin I elevation and normal creatinin phosphokinase. Int J Cardiol. 2004; 97 (2) : 221-224.

  1. xliiThomas W et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006; 113 : 1958-1965.

  1. xliiiIliou MC. et al. Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients : Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study. Nephrol Dial Transplant. 2001; 16 : 1452-1458.

  1. xlivFrancis GS et al. Cardiac troponins in renal insufficiency and other non-ischemic cardiac conditions. Prog Cardiovasc Dis. 2004; 7 : 196-206.

  1. xlvRicchiutti and F.S. Apple, RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle. Clin Chem. 45 1999; 2129–2135.

  1. xlviPopowska-Drojecka et al. Increased serum levels of troponin I and lesions in coronary angiography in hemodialysed patients. Rocz Akad Med Bialymst 2005; 50 : 311-313.

  1. xlviiAbaci A et al. Cardiac troponin T and I in patients with end-stage renal disease : the relation with left ventricular mass and their prognostic value. Clin Cardiol. 2004; 27 (12) : 704-709.

  1. xlviiiMallamaci F et al. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2002; 40 (1) : 68-75.

  1. xlixKanwar M et al. Usefulness of clinical evaluation, troponins and C-reactive protein in predicting mortality among stable hemodialysis patients. Am J Cardiol. 2006; 98 (9) : 1283-1287.

  1. lApple FS et al. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002; 106 : 2941-2946.

  1. liDeléaval P. et al. Differences in cardiac troponin I and T levels measured in asymptomatic hemodialysis patients with last generation immunoassays. Nephrol Ther. 2006; 2 (2) : 75-81.

  1. liiRoppolo LP et al. A comparaison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a Veteran’s Hospital : a pilot study. J Am Coll Cardiol. 1999; 34 : 448-454.

  1. liiiAviles RJ et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med. 2002; 346 : 2047-2052.

  1. livBhayana V et al. Discordance between results for serum troponin T and I in renal disease. Clin Chem. 1995; 41 (2) : 312-317.

  1. lvFreda BJ et al. Cardiac troponins in renal insufficiency : review and clinical implications. J Am Coll Cardiol. 2002; 40 : 2065-2071.

  1. lviKontos MC et al. Outcomes in patients admitted for chest pain with renal failure and troponin I elevations. Am Heart J. 2005; 150 (4) : 674-680.

  1. lviiLowobeer C et al. Elevated cardiac troponin T in peritoneal dialysis patients is associated with CRP and predicts all-cause mortality and cardiac death. Nephrol Dial Transplant. 2002; 17 (12) : 2178-2183.

  1. lviiiZoccali C. et al. A green light for troponin T in the cardiovascular risk stratification of continuous ambulatory peritoneal dialysis patients? Kidney Int. 2006; 70 (3) : 408-410.

  1. lixWu AH et al. Cardiac troponin T and I before and after renal transplantation. Clin Chem. 1997; 43 (2) : 411-413.

  1. lxBozbas H et al. Serum levels of cardiac enzymes before and after renal transplantation. Clin Cardiol. 2004; 27 (10) : 559-562.

  1. lxiJackson L et al. Best evidence topic report. Use of troponin for diagnosis of myocardial contusion after blunt chest trauma. Emerg Med J. 2005; 22 : 193- 198.

  1. lxiiSybrandy et al. Diagnosing cardiac contusion : old wisdom and new insights. Heart 2003; 89 : 485-489.

  1. lxiiiBertinchant JP et al. Evaluation of incidence, clinical significance, and prognostic value of circulating cardiac troponin I and T elevation in hemodynamically stable patients with suspect myocardial contusion after blunt chest trauma. J Trauma. 2000; 48 : 924-931.
1   2   3   4   5   6   7   8   9   10

similaire:

Bibliographie Introduction iconBibliographie Introduction

Bibliographie Introduction iconBibliographie Introduction

Bibliographie Introduction iconBibliographie introduction

Bibliographie Introduction iconBibliographie Introduction à l'étude de la médecine expérimentale

Bibliographie Introduction iconBibliographie Introduction
«rurale» à certains comportements qualitatifs uniquement (respect des traditions, etc.)

Bibliographie Introduction iconBibliographie. Introduction
«à simplifier et à clarifier les modalités d’organisation des projets pour les sorties scolaires»

Bibliographie Introduction iconBibliographie 1- introduction
«difficiles, résistants et manipulateurs». Par le biais de ces invalidations réitérées, la boucle de la répétition du traumatisme...

Bibliographie Introduction iconBibliographie 44 Table des matières 47 introduction la biomécanique...

Bibliographie Introduction icon9-Bibliographie 1- introduction
«classique» (type pavlovien) et «opérant» tel celui mis en place 20 ans après les expériences de Pavlov par le psychologue Skinner...

Bibliographie Introduction iconBibliographie thématique restreinte (1995-2006) Vous pouvez consulter...








Tous droits réservés. Copyright © 2016
contacts
b.21-bal.com